8-KThe WireRoutine
Reg FD Disclosure
Filed Nov 4, 2024 · 1y ago · Accession 0000950170-24-120267
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Viking Therapeutics, Inc.
- Ticker
- VKTX
- CIK
- 1607678
- Form type
- 8-K
- Filing date
- Nov 4, 2024
- Report date
- Nov 4, 2024
- Document
- vktx-20241104.htm
- Size
- 332 KB